S1PR2 deficiency enhances neuropathic pain induced by partial sciatic nerve ligation

Background/aim: Sphingosine 1-phosphate receptor 2 (S1PR2), a member of the seven-transmembrane receptor family, can beactivated by its natural ligand sphingosine 1-phosphate (S1P) to initiate signal transduction and is involved in a wide range of biologicaleffects such as immune cell migration and vascular permeability. Its relationship with neuropathic pain (NP) has not been reported. Inthis study, the effects of S1PR2 on the development of NP were studied.Materials and methods: We generated a model of NP by partial sciatic nerve ligation (pSNL). The 50% paw withdrawal threshold ofthe wild-type (WT) group and the S1PR2 deficiency group were measured at several time points after surgery. The inflammatory factorlevels of the two groups were measured by real-time quantitative polymerase chain reaction (RT-PCR). Neutrophil infiltration and glialcell activation were detected by immunofluorescence. Matrix metalloproteinase 9 (MMP9) and its substrate myelin basic protein (MBP)were measured by RT-PCR, western blotting, and immunofluorescence.Result: The S1PR2 deficiency group showed a reduction in 50% paw withdrawal threshold compared with WT mice (P < 0.05) at 3 daysafter the operation. In the ligated sciatic nerve of the S1PR2 deficiency group, the mRNA expression of IL-1β was increased; the numbersof infiltrating neutrophils and activated astrocytes were also increased. The expression of MMP9 was elevated while MBP was decreased.Conclusion: S1PR2 deficiency could increase the pain sensitivity of a NP mouse model and promote the development of NP.

PDF

___

1. Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS et al. A new definition of neuropathic pain. Pain 2011; 152: 2204- 2205.
2. Harifi G, Amine M, Ait Ouazar M, Boujemaoui A, Ouilki I, Rekkab I et al. Prevalence of chronic pain with neuropathic characteristics in the Moroccan general population: a national survey. Pain Medicine 2013; 14: 287-292.
3. Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurology 2012; 11: 629-642.
4. Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S. Sphingosine 1-phosphate receptor signaling. Annual Review of Biochemistry 2009; 78: 743-768.
5. Moriyama S, Takahashi N, Green JA, Hori S, Kubo M, Cyster JG et al. Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers. Journal of Experimental Medicine 2014; 211: 1297-1305.
6. Zhang G, Yang L, Kim GS, Ryan K, Lu S, O’Donnell RK et al. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 2013; 122: 443-455.
7. Kempf A, Tews B, Arzt ME, Weinmann O, Obermair FJ, Pernet V et al. The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. PLoS Biology 2014; 12: e1001763.
8. Liou JT, Lee CM, Lin YC, Chen CY, Liao CC, Lee HC et al. P-selectin is required for neutrophils and macrophage infiltration into injured site and contributes to generation of behavioral hypersensitivity following peripheral nerve injury in mice. Pain 2013; 154: 2150-2159.
9. Tan AM, Chang YW, Zhao P, Hains BC, Waxman SG. Rac1-regulated dendritic spine remodeling contributes to neuropathic pain after peripheral nerve injury. Experimental Neurology 2011; 232: 222-233.
10. Liu MG, Koga K, Guo YY, Kang SJ, Collingridge GL, Kaang BK et al. Long-term depression of synaptic transmission in the adult mouse insular cortex in vitro. European Journal of Neuroscience 2013; 38: 3128-3145.
11. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 1998; 76: 215-222.
12. Haraguchi K, Kawamoto A, Isami K, Maeda S, Kusano A, Asakura K et al. TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. Journal of Neuroscience 2012; 32: 3931-3941.
13. Liou JT, Yuan HB, Mao CC, Lai YS, Day YJ. Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model. Pain 2012; 153: 1283-1291.
14. Chattopadhyay S, Myers RR, Janes J, Shubayev V. Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain, behavior, and Immunity 2007; 21: 561-568.
15. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. Journal of Cerebral Blood Flow and Metabolism 2003; 23: 1430-1440.
16. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH et al. Distinct roles of matrix metalloproteases in the early- and latephase development of neuropathic pain. Nature Medicine 2008; 14: 331-336.
17. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-291.
18. Yong VW. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nature Reviews Neuroscience 2005; 6: 931-944.
19. Hung HA, Sun G, Keles S, Svaren J. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury. Journal of Biological Chemistry 2015; 290: 6937-6950.
20. Kurzepa J, Kurzepa J, Golab P, Czerska S, Bielewicz J. The significance of matrix metalloproteinase (MMP)-2 and MMP9 in the ischemic stroke. International Journal of Neuroscience 2014; 124: 707-716.
21. Weber A, Wasiliew P, Kracht M. Interleukin-1β (IL-1β) processing pathway. Science Signaling 2010; 3: cm2.
22. Luheshi NM, Giles JA, Lopez-Castejon G, Brough D. Sphingosine regulates the NLRP3-inflammasome and IL-1beta release from macrophages. European Journal of Immunology 2012; 42: 716-725.
23. Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome. Immunological Reviews 2011; 243: 152-162.
24. Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nature Reviews Neuroscience 2014; 15: 84-97.
25. Dev R, Srivastava PK, Iyer JP, Dastidar SG, Ray A. Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain. Expert Opinion on Investigational Drugs 2010; 19: 455- 468.
26. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Reviews Immunology 2004; 4: 617-629.
27. Boggs JM. Myelin basic protein: a multifunctional protein. Cellular and Molecular Life Sciences 2006; 63: 1945-1961.

Turkish Journal of Medical Sciences-Cover

ISSN: 1300-0144
Yayın Aralığı: Yılda 6 Sayı
Yayıncı: TÜBİTAK

Arşiv

Sayıdaki Diğer Makaleler

Rafiye ÇİFTÇİLER, Ahmet KOLUMAN, İbrahim Celalettin HAZNEDAROĞLU, Nejat AKAR

Filiz KAYA, Ahmet Çağkan İNKAYA, Ali İhsan ERTENLİ, Osman ABBASOĞLU, Sercan AKSOY, Yakut Akyön YILMAZ, Sibel ERGÜVEN

Ayşegül İdil SOYLU, Korhan SOYLU, Ramazan AYDIN, Fatih UZUNKAYA, Kerim ASLAN, Ahmet Veysel POLAT

Arzu Güçlü GÜNDÜZ, Gökhan YAZICI, Çağla ÖZKUL, Hamit KÜÇÜK, Hale Zeynep Batur ÇAĞLAYAN, Bijen NAZLIEL

Serdar KARAKAYA, Mustafa ALTAY, Fatma Kaplan EFE, İbrahim KARADAĞ, Oktay ÜNSAL, Oktay BULUR, MURAT ESER, Derun Taner ERTUĞRUL

A comparative biomechanical analysis of suprapectineal and infrapectineal fixation on acetabular anterior column fracture by finite element modeling

Ahmet Özgür YILDIRIM, Mehmet YÜCENS, Nevres H. AYDOĞAN, Kadir Bahadır ALEMDAROĞLU, Serkan İLTAR, Ahmet ÖZMERİÇ

The effects of uterine size with or without abdominal obesity on spinal block level and vasopressor requirement in elective cesarean section: a prospective observational study

Ahmet Mete ERGENOĞLU, Ali AKDEMİR, İlkben GÜNÜŞEN, Asuman SARGIN

Şeyda Figül GÖKÇE, Burhanettin ÇİĞDEM, Sanem Nemmezi KARACA, Asli BOLAYIR, Özlem Kayim YILDIZ, Ahmet Suat TOPAKTAŞ, Hatice BALABAN

Hamza ÖZAVCI, Mustafa KAPLAN

Sadettin ER, Sabri ÖZDEN, Faruk KOCA, Bariş Doğu YILDIZ, Bülent Cavit YÜKSEL, Mesut TEZ